Compare Booking Holdings Inc (BKNG) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Booking Holdings Inc vs BIO-TECHNE Corp — how do they compare? Booking Holdings Inc trades at $212.85 (market cap $159.95B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: Booking Holdings Inc is far larger — about 14.2× BIO-TECHNE Corp's market cap, and Booking Holdings Inc pays the higher dividend (0.79%). Which is the better fit depends on your goals.
| BKNG | TECH | |
|---|---|---|
Market Cap | $159.95B | $11.24B |
Sector | Consumer Cyclical | Health |
52-Week High | $228.83 | $72.29 |
52-Week Low | $154.13 | $43.31 |
Enterprise Value | $163.43B | $11.32B |
Dividend Yield | 0.79% | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BKNG trades at $214.42, up 3.39% on strong Q2 2026 earnings beats, with bullish technical signals and a consensus price target of $239.31. Revenue growth accelerated to $26.92B in 2025, though net income dipped to $5.40B. The stock shows robust profitability with a 25.53% net margin and high ROE, but faces geopolitical and competitive pressures.
Outlook remains positive with resilient travel demand and AI integration driving efficiency, but risks include Middle East volatility and high debt levels. Analysts are overwhelmingly bullish with 64% buy ratings, supporting upside potential amid near-term headwinds.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Booking Holdings Inc
Booking is the world's largest online travel agency by revenue, offering booking and payment services for hotel and alternative accommodation rooms, airline tickets, rental cars, restaurant reservations, cruises, experiences, and other vacation packages. The company operates a number of branded travel booking sites, including Booking.com, Agoda, OpenTable, and Rentalcars.com, and has expanded into travel media with the acquisitions of Kayak and Momondo. Transaction fees for online bookings account for the bulk of revenue and profits.
Read more on BKNG →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
